Back
Invesco DB Commodity Index Tracking Fund Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
42
DBC
Invesco DB Commodity Index Tracking Fund
Last Price:
$21.80
Seasonality Move:
-0.48%
Buy
70
SRPT
Sarepta Therapeutics
Last Price:
$20.99
Seasonality Move:
8.12%
Sell
42
Invesco DB Commodity Index Tracking Fund (DBC)
is a Sell
Is Invesco DB Commodity Index Tracking Fund a Buy, Sell or Hold?
-
The current Invesco DB Commodity Index Tracking Fund [DBC] share price is $21.77. The Score for DBC is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
DBC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $21.81. The Score for SRPT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DBC Stock Price Chart
What is Invesco DB Commodity Index Tracking Fund's stock price today?
-
The Invesco DB Commodity Index Tracking Fund share price today is $21.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBC is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $21.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
DBC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.3 | Buy |
Relative Strength Index (14 RSI): | 40.32 | Sell |
Chaikin Money Flow: | 13974 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.86 - 22.48) | Sell |
Bollinger Bands (100): | (21.07 - 22.39) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.03 | Buy |
Relative Strength Index (14 RSI): | 61.42 | Buy |
Chaikin Money Flow: | 6597638 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.11 - 19.59) | Buy |
Bollinger Bands (100): | (17.55 - 53.77) | Sell |
DBC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.81 | Sell |
20-day SMA: | 22.12 | Sell |
50-day SMA: | 22.18 | Sell |
200-day SMA: | 21.94 | Sell |
8-day EMA: | 21.19 | Buy |
20-day EMA: | 16.52 | Buy |
50-day EMA: | 9.42 | Buy |
200-day EMA: | 2.87 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.96 | Buy |
20-day SMA: | 16.47 | Buy |
50-day SMA: | 20.62 | Buy |
200-day SMA: | 75.35 | Sell |
8-day EMA: | 18.91 | Buy |
20-day EMA: | 13.99 | Buy |
50-day EMA: | 7.79 | Buy |
200-day EMA: | 2.35 | Buy |
Invesco DB Commodity Index Tracking Fund Earnings Growth & DBC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $1.27 per share, a decrease this year of $5.65 per share, and an increase next year of $5.32 per share.
Invesco DB Commodity Index Tracking Fund Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |